14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 AKBA stock ended at $1.40. This is 6.04% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 13.04% from a day low at $1.38 to a day high of $1.56.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Akebia Therapeutics prices

Date Open High Low Close Volume
Nov 21, 2016 $8.93 $9.02 $8.81 $8.99 111 579
Nov 18, 2016 $9.03 $9.04 $8.84 $8.96 141 953
Nov 17, 2016 $8.72 $9.04 $8.72 $8.98 258 418
Nov 16, 2016 $8.60 $8.99 $8.57 $8.85 194 761
Nov 15, 2016 $9.14 $9.14 $8.63 $8.65 247 806
Nov 14, 2016 $8.87 $8.96 $8.74 $8.90 448 365
Nov 11, 2016 $8.66 $8.88 $8.40 $8.77 384 748
Nov 10, 2016 $8.83 $9.20 $8.57 $8.63 388 338
Nov 09, 2016 $8.21 $8.65 $7.90 $8.63 274 059
Nov 08, 2016 $7.80 $7.80 $7.80 $7.80 110 684
Nov 07, 2016 $7.84 $7.84 $7.84 $7.84 161 200
Nov 04, 2016 $7.37 $7.37 $7.37 $7.37 124 500
Nov 03, 2016 $7.19 $7.19 $7.19 $7.19 125 300
Nov 02, 2016 $7.33 $7.33 $7.33 $7.33 98 300
Nov 01, 2016 $7.49 $7.49 $7.49 $7.49 88 100
Oct 31, 2016 $7.52 $7.52 $7.52 $7.52 99 200
Oct 28, 2016 $7.58 $7.58 $7.58 $7.58 124 600
Oct 27, 2016 $7.63 $7.63 $7.63 $7.63 93 900
Oct 26, 2016 $7.71 $7.71 $7.71 $7.71 69 400
Oct 25, 2016 $7.81 $7.81 $7.81 $7.81 55 500
Oct 24, 2016 $7.89 $7.89 $7.89 $7.89 54 700
Oct 21, 2016 $8.09 $8.09 $8.09 $8.09 65 100
Oct 20, 2016 $8.20 $8.20 $8.20 $8.20 125 400
Oct 19, 2016 $8.02 $8.02 $8.02 $8.02 114 600
Oct 18, 2016 $8.03 $8.03 $8.03 $8.03 99 700
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT